Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, offering promising developments across many healthcare and industrial purposes. With its structural similarity to The natural way derived human serum albumin, OsrHSA offers a safer, much more reliable substitute for therapeutic use,